TNYA · ISSUER CIK 1858848
Tenaya Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Tenaya Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $21K of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$21KInsider selling
−$21KNet open-market
Sep 11, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 202620:10 | Sep 10, 2026 | TNYA | Chief Executive Officer, Director | A · Grant | — | +122,000 | 539,782 | +29% | — | ||
| Sep 11, 202620:10 | Sep 10, 2026 | TNYA | Chief Medical Officer | A · Grant | — | +49,000 | 263,073 | +23% | — | ||
| Aug 17, 202620:50 | Aug 17, 2026 | TNYA | Chief Executive Officer, Director | S · Sell | $0.71 | −22,232 | 417,782 | -5% | −$16K | ||
| Aug 17, 202620:49 | Aug 17, 2026 | TNYA | Chief Medical Officer | S · Sell | $0.71 | −7,424 | 214,073 | -3% | −$5K |